On 24 September, the European Commission launched work on the revision of the legislation applicable to plants produced using certain new genomic techniques.
For this revision, the Commission has launched a public consultation until 22 October and has published an Inception Impact Assessment.
In order to facilitate the marketing of safe plants obtained by targeted cisgenesis and mutagenesis and to improve European competitiveness, the Commission states that the assessment procedures should...